Marlena Nastassja Stadtmüller (Marlena Nastassja Schlecht, Marlena Stadtmüller, Marlena N Schlecht)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 9

Top Topics

Hyaluronic Acid

Respiratory Syndrome Coronavirus

Top Venues

Science advances

Proceedings of the National Academy of Sciences of the United States of America

Emerging microbes & infections

This page only lists publications with an associated author ORCID identifier.

Publications

Anne von Mässenhausen, Marlena Nastassja Stadtmüller, Kristina Beer, Francesca Maremonti, Wulf Tonnus, Alexia Belavgeni, Shubhangi Gavali, Karolin Flade, Joel S Riley, Nadia Zamora Gonzalez, Anne Brucker, Jorunn Naila Becker, Mirela Tmava, Claudia Meyer, Mirko Peitzsch, Christian Hugo, Florian Gembardt, Jose Pedro Friedmann Angeli, Stefan R Bornstein, Stephen W G Tait, Andreas Linkermann
Treatment with siRNAs is commonly associated with GPX4 up-regulation and target knockdown-independent sensitization to ferroptosis. Science advances 10 (11) (2024)
Anne von Mässenhausen, Marlena Nastassja Stadtmüller, Kristina Beer, Francesca Maremonti, Wulf Tonnus, Alexia Belavgeni, Shubhangi Gavali, Karolin Flade, Joel S Riley, Nadia Zamora Gonzalez, Anne Brucker, Jorunn Naila Becker, Mirela Tmava, Claudia Meyer, Mirko Peitzsch, Christian Hugo, Florian Gembardt, Jose Pedro Friedmann Angeli, Stefan R Bornstein, Stephen W G Tait, Andreas Linkermann
Treatment with siRNAs is commonly associated with GPX4 up-regulation and target knockdown-independent sensitization to ferroptosis. Science advances 10 (11) (2024)
Anne von Mässenhausen, Marlena Nastassja Stadtmüller, Kristina Beer, Francesca Maremonti, Wulf Tonnus, Alexia Belavgeni, Shubhangi Gavali, Karolin Flade, Joel S Riley, Nadia Zamora Gonzalez, Anne Brucker, Jorunn Naila Becker, Mirela Tmava, Claudia Meyer, Mirko Peitzsch, Christian Hugo, Florian Gembardt, Jose Pedro Friedmann Angeli, Stefan R Bornstein, Stephen W G Tait, Andreas Linkermann
Treatment with siRNAs is commonly associated with GPX4 up-regulation and target knockdown-independent sensitization to ferroptosis. Science advances 10 (11) (2024)
Badri Parshad, Marlena Nastassja Stadtmüller, Morris Baumgardt, Kai Ludwig, Chuanxiong Nie, Agustina Rimondi, Katja Hönzke, Stefano Angioletti-Uberti, Vinod Khatri, Paul Schneider, Andreas Herrmann, Rainer Haag, Andreas C Hocke, Thorsten Wolff, Sumati Bhatia
Dual-Action Heteromultivalent Glycopolymers Stringently Block and Arrest Influenza A Virus Infection In Vitro and Ex Vivo . Nano letters (2023)
Michaela Lackner, Annika Rössler, André Volland, Marlena Nastassja Stadtmüller, Brigitte Müllauer, Zoltan Banki, Johannes Ströhle, Angela Luttick, Jennifer Fenner, Bettina Sarg, Leopold Kremser, Paul Tone, Heribert Stoiber, Dorothee von Laer, Thorsten Wolff, Carsten Schwarz, Markus Nagl
N-chlorotaurine is highly active against respiratory viruses including SARS-CoV-2 (COVID-19) in vitro . Emerging microbes & infections 11 (1) (2022)
Marlena Nastassja Stadtmüller, Alexa Laubner, Fabian Rost, Sylke Winkler, Eva Patrasová, Lenka Šimůnková, Susanne Reinhardt, Johanna Beil, Alexander H Dalpke, Buqing Yi
Emergence and spread of a sub-lineage of SARS-CoV-2 Alpha variant B.1.1.7 in Europe, and with further evolution of spike mutation accumulations shared with the Beta and Gamma variants. Virus evolution 8 (1) (2022)
Alexia Belavgeni, Francesca Maremonti, Marlena Nastassja Stadtmüller, Stefan R Bornstein, Andreas Linkermann
Schwann cell necroptosis in diabetic neuropathy. Proceedings of the National Academy of Sciences of the United States of America 119 (17) (2022)
Chuanxiong Nie, Marlena Nastassja Stadtmüller, Badri Parshad, Matthias Wallert, Vahid Ahmadi, Yannic Kerkhoff, Sumati Bhatia, Stephan Block, Chong Cheng, Thorsten Wolff, Rainer Haag
Heteromultivalent topology-matched nanostructures as potent and broad-spectrum influenza A virus inhibitors. Science advances 7 (1) (2021)
Buqing Yi, Anna R Poetsch, Marlena Nastassja Stadtmüller, Fabian Rost, Sylke Winkler, Alexander H Dalpke
Phylogenetic analysis of SARS-CoV-2 lineage development across the first and second waves in Eastern Germany in 2020: insights into the cause of the second wave. Epidemiology and infection 149 (2021)